Wall Street shrugs off FDA’s Gardasil rejection
Many Wall Street analysts greeted the FDA's decision to reject Merck's bid to expand the use of Gardasil to 27 to 45-year-old women with a yawn. For many on Wall Street, the key market for the
Merck's rotavirus vaccine makes big impact
A new report by the CDC concludes that Merck's new rotavirus vaccine has made a major impact on the disease in the last two years. RotaTeq, designed to prevent diarrhea and vomiting in children, has
Gates and GAVI gear up global vaccine initiative
The Global Alliance for Vaccines and Immunization, which is backed by a host of international health groups and the Gates Foundation, is preparing a huge new initiative to vaccinate millions of
Sanofi to invest $6B in vaccine production
The growing wealth seen in developing nations is spurring a big increase in the worldwide demand for vaccines, and Sanofi-Aventis says it will invest more than $6 billion over the next eight years in
$200M vaccine plant for China; Researchers advance bowel cancer vaccine;
Vaccine Market Canada's Microbix Biosystems is plotting a $200 million flu vaccine plant in Hunan province. The cooperative deal puts Microbix in partnership with the Hunan government, which will put
AmVac forges collaboration; Sanofi to donate flu vaccine; Vaccines in space;
Bavarian Nordic reports success in breast cancer trials
Bavarian Nordic says that an interim analysis of two clinical trials of its experimental breast cancer vaccine shows that the therapy appears to be well tolerated and immunogenic. No adverse events
Novartis yanks pre-pandemic vaccine application
Faced with a looming deadline to provide more data on the pre-pandemic vaccine Aflunov, Novartis Vaccines and Diagnostics has pulled its application for centralized marketing authorization from the
Australia approves a new bird flu vaccine
Australian officials have approved a bid flu vaccine developed by CSL. And the government announced a $160 million budget to stockpile additional vaccines to help protect the country from an
UK health officials in cancer vaccine fight
When British health officials weighed the benefits of the two cervical cancer vaccines, they concluded that Cervarix from GlaxoSmithKline provided the best value for the money. And that decision
Human trial for Cuban cancer vaccine; Experts question HIV vaccine trial;
Celldex inks tech deal to advance cancer vaccines
Celldex Therapeutics has struck a deal to use 3M's toll-like receptor (TLR) agonist compounds--useful as vaccine adjuvants--for a slate of new oncology vaccines in development. 3M Drug Delivery
Glaxo touts effectiveness of pediatric vaccine candidate
GlaxoSmithKline is touting new, late-stage data that demonstrates how its experimental pediatric vaccine Synflorix effectively protects children from pneumococcal disease. Glaxo filed Synflorix for
Iomai reports success with traveler’s diarrhea patch
Iomai has racked up more positive data for its vaccine patch to prevent traveler's diarrhea. A new study details that only three of 59 volunteers who used the patch experienced a severe or moderate
Cell-based pandemic vaccine successful in human trial
Baxter International says that a human trial of its Celvapan bird flu vaccine demonstrated that it spurred an immune response against three strains of the lethal virus. This is the first time that
Novartis plans trials for growing vaccines pipeline
Novartis is taking the wraps off its vaccine pipeline, highlighting plans for new trials as it talks up a lineup of vaccine candidates. Researchers for the company detailed plans that include a
Vaccine research heads to outer space
A program to develop a new salmonella vaccine has headed to the outer limits. The space shuttle Discovery is carrying a test strain of salmonella, and officials at Spacehab are using the experiment
SPOTLIGHT: Brain cancer vaccine doubles survival time
An experimental brain cancer vaccine more than doubled the survival time of patients suffering from glioblastoma multiforme. Early-stage data demonstrated that patients lived almost three years
THE LIBRARY: WEBINAR
Proactive Planning: How Supply Chain Risk Mapping Can Prevent Costly Disruptions
Biopharma companies can never eliminate the risk of supply chain disruption, but they can prevent some problems and prepare themselves for others. Knowing every company in the supply chain--from tier one down--and having contingency plans in place are essential steps to foreseeing and responding to disruptions. Maps of supply chain risks give companies this knowledge. Register Now!
Latest Commentary
Combating HIV: The future of therapeutic vaccines
10 promising therapeutic vaccines in 2012
The 20 top-selling vaccines in H1 2012
GeoVax: Meeting the HIV vaccine challenge
Wishing you a happy HIV Vaccine Awareness Day
more
EVENTS
- Drug Development ImmersionSeptember 24-25 — New York, NY — Sponsored by: BioTech Primer
- BioImmersionOctober 14-16 — Chicago, IL — Sponsored by: Biotech Primer
- BioBasics: Biotech for the Non-ScientistDecember 3-4 — Boston, MA — Sponsored by: BioTech Primer